Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
RESEARCH TOOLSreports
FLERIE Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr37.21 - kr52.60
Previous CloseN/A
Volume1.84K
Average Volume (3M)63.36K
Market Cap
kr3.61B
Enterprise Valuekr2.52B
Total Cash (Recent Filing)kr802.10M
Total Debt (Recent Filing)kr800.00K
Price to Earnings (P/E)0.3
Beta-0.12
Next Earnings
Jul 31, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.21
Shares Outstanding78,066,410
10 Day Avg. Volume97,116
30 Day Avg. Volume63,356
Financial Highlights & Ratios
PEG Ratio2.46
Price to Book (P/B)8.58
Price to Sales (P/S)0.00
P/FCF Ratio-22.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
FLERIE FAQ
What was InDex Pharmaceuticals Holding AB’s price range in the past 12 months?
InDex Pharmaceuticals Holding AB lowest stock price was kr37.21 and its highest was kr52.60 in the past 12 months.
What is InDex Pharmaceuticals Holding AB’s market cap?
InDex Pharmaceuticals Holding AB’s market cap is kr3.61B.
When is InDex Pharmaceuticals Holding AB’s upcoming earnings report date?
InDex Pharmaceuticals Holding AB’s upcoming earnings report date is Jul 31, 2025 which is in 45 days.
How were InDex Pharmaceuticals Holding AB’s earnings last quarter?
InDex Pharmaceuticals Holding AB released its earnings results on Apr 16, 2025. The company reported -kr3.215 earnings per share for the quarter, missing the consensus estimate of N/A by -kr3.215.
Is InDex Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts InDex Pharmaceuticals Holding AB’s price is currently Overvalued.
Does InDex Pharmaceuticals Holding AB pay dividends?
InDex Pharmaceuticals Holding AB does not currently pay dividends.
What is InDex Pharmaceuticals Holding AB’s EPS estimate?
InDex Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InDex Pharmaceuticals Holding AB have?
InDex Pharmaceuticals Holding AB has 78,066,410 shares outstanding.
What happened to InDex Pharmaceuticals Holding AB’s price movement after its last earnings report?
InDex Pharmaceuticals Holding AB reported an EPS of -kr3.215 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.986%.
Which hedge fund is a major shareholder of InDex Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in SE:FLERIE
Company Description
InDex Pharmaceuticals Holding AB
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Technical Analysis
Hansa Biopharma AB
―
BioInvent International AB
―
Vicore Pharma Holding AB
―
Xspray Pharma AB
―
SynAct Pharma AB
―